Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Eitemau Tebyg

• Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
  gan: Osbak, K, et al.
  Cyhoeddwyd: (2009)
• Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
  gan: Thomson, K, et al.
  Cyhoeddwyd: (2003)
• Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
  gan: Li, Xiuzhen, et al.
  Cyhoeddwyd: (2018)
• Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
  gan: Turkkahraman, D, et al.
  Cyhoeddwyd: (2008)
• Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
  gan: Gloyn, A, et al.
  Cyhoeddwyd: (2002)